Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2025-12-24 @ 11:34 PM
NCT ID: NCT05376956
Eligibility Criteria: Inclusion Criteria: * Subjects with age group between 20 to 60 years with sedentary lifestyle will be included. * both males and females will be included. * Patients with diagnosed Tight hamstrings having knee extension less than 160º with the hip at 90º flexion. * Patients with decreased ROM at the knee joint. * Patients with reduced straight leg raise. * Patients with pain in posterior compartment of thigh. * Asymptomatic patients will be included. * Patients with restricted mobility of lower limb due to Hamstring shortness. * Symptomatic patients with hamstring tightness like of low back pain, pelvic tightness, knee osteoarthritis (grade 1 and 2) are included in the research. Exclusion Criteria: * Patients with prolapsed disc will excluded.(14) * Patients with lower extremity injuries (strain, sprain, ligament injuries, etc.) in last 6 months will be excluded. * Patients with severe hamstring injury either acute or chronic will be excluded. * Patients with visual acute swelling in the region of hamstring muscle * Patients with fracture of any type and area. * Patients with dislocations or subluxations present will be excluded. * Patient recommended for TKR of knee joint. * Patients with any neurological disease like lumbar/cervical herniation, polyneuropathy, scoliosis etc.) * Patient with any tumor of hip or knee with traumatic brain injury, spinal cord injuries will be excluded.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 20 Years
Maximum Age: 60 Years
Study: NCT05376956
Study Brief:
Protocol Section: NCT05376956